Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy.

Authors
  • 1
  • 1 Department of General Thoracic Surgery, Kawasaki Medical School Hospital, Kurashiki, Okayama, Japan. [email protected] , (Japan)
Type
Published Article
Journal
Interactive Cardiovascular and Thoracic Surgery
1569-9285
Publisher
Oxford University Press
Publication Date
Volume
16
Issue
2
Pages
166–172
Identifiers
DOI: 10.1093/icvts/ivs450
PMID: 23143203
Source
Medline
License
Unknown

Abstract

The prognosis of patients with NSCLC recurrence after surgery is currently improving. Our results suggested two new prognostic factors, adjuvant chemotherapy and EGFR mutations, neither of which have been previously reported. Treatment strategies for postoperative recurrence should be established based on a more detailed subdivision of factors, such as histology and molecular markers, in the future.

Statistics

Seen <100 times